The PWP Discover Series brings together leading physicians, patients, care partners, health care professionals, researchers, and the Parkinson’s Disease care team of each hospital system to speak about their best practices and health concerns. These top-tier specialists will share their knowledge and expertise on best strategies for staying well and leading a healthier life. Each healthcare system will discuss themes of their choice.
LIVE and on ZOOM
EVENT FREE — DONATIONS WELCOME
A Round Table discussion will be held on how each health system works together with patients and families.
Dr. Hiral Shah is an assistant professor of neurology at CUMC in the Division of Multispecialty Neurology. Dr. Shah completed her undergraduate at MIT and her medical doctorate at Indiana University School of Medicine. Dr. Shah completed her neurology residency at Columbia, serving as chief resident in her final year. Dr. Shah subsequently spent nearly a year at the World Health Organization (WHO) in Geneva, working in the Department of Mental Health and Substance Abuse on public health aspects of neurological illnesses. She is currently a Global Mental Health Scholar, and also serves as coordinator for WHO’s project on dementia prioritization and G7 Dementia Research Agenda portfolio analysis. In addition, Dr. Shah is a Global Health and Aging Policy Fellow, with plans to examine best practices surrounding human rights protection for those with cognitive impairment and dementia. Dr. Shah is most interested in learning how to overcome barriers of stigma and discrimination to improve care access for vulnerable individuals who suffer from mental health conditions and neurodegenerative disorders. This includes the assessment of cognition and mental health among those with neuropsychiatric conditions.
Dr. O’Shea sees patients with all movement disorders including Parkinson’s disease, Huntington’s disease, atypical parkinsonism, tremor, ataxia, chorea and dystonia. She specializes in Deep Brain Stimulation (DBS) for movement disorders, including patient selection, evaluation, intra-operative assessments, and post-operative programming. She is also skilled in neurotoxin injections for movement disorders and spasticity.
Dr. O’Shea’s research interests include investigating prodromal biomarkers of Parkinson’s disease and the effects of neurotoxicant exposure on the development of neurodegenerative disease. She also leads several clinical trials for Parkinson’s disease and Huntington’s disease. Her research has previously been funded by the American Parkinson’s Disease Association (APDA).
Dr. O’Shea is a member of the International Parkinson and Movement Disorder Society (MDS) and American Academy of Neurology (AAN). She is a credentialed member of the Parkinson Study Group (PSG) and Huntington Study Group (HSG). She was also appointed to serve on the exam writing committee for the American Board of Psychiatry and Neurology (ABPN).
Dr. Sarah O’Shea is an Assistant Professor of Neurology in the Columbia University Vagelos College of Physician and Surgeons. She obtained her medical doctorate at the University of Illinois. She completed her residency training and served as Chief Resident in Neurology at the University of Iowa Hospitals and Clinics. She then completed her fellowship training in Movement Disorders at Columbia University Medical Center and completed the Neuroepidemiology Training Program (NETP, Master of Science in Epidemiology) during her training at Columbia University. Prior to joining the faculty at Columbia, Dr. O’Shea was an Assistant Professor of Neurology in the Division of Movement Disorders at Boston University School of Medicine.
Dr. Julian Agin-Liebes is an assistant professor of neurology in the Movement Disorders division. Dr. Agin-Liebes completed his medical degree at the Medical School for International Health at Ben Gurion University in Israel. He completed his internship in Internal Medicine followed by his residency in Neurology at Rutgers New Jersey Medical School and served as chief resident in his final year. He completed his fellowship in movement disorders at Columbia University Medical Center. He conducts research into the pathophysiology of Parkinson’s disease with a focus on genetics and biomarkers and is involved in clinical trials for Parkinson’s disease. He is also the director of the Parkinson’s Foundation Brain Bank.
THANKS TO SPONSORS
